Zender and colleagues in their oncogenomics-based in vivo RNAi screen demonstrated that the reintroduction of XPO4 selectively suppresses tumors including HCC with XPO4 deletion11. The gene discussed is XPO4; the disease is hepatocellular carcinoma.